Bni5p is a scaffolding protein that interacts with septins (Cdc3p, Cdc10p, Cdc11p, Cdc12p, and Sep7p) and myosin-II (Myo1p) to stabilize the septin ring at the mother-bud neck. This stabilization is essential for cytokinesis, actin cable retrograde flow, and asymmetric segregation of protein aggregates . Antibodies targeting Bni5p enable researchers to investigate its localization, interactions, and functional dynamics.
BNI5 antibodies are typically generated against epitope-tagged versions of the protein, such as GFP-, HA-, or myc-tagged constructs. These antibodies are used in:
Immunofluorescence (IF): Visualizing Bni5p’s cell cycle-dependent localization at the bud neck .
Western blotting (WB): Confirming protein expression levels in mutants or overexpression strains .
Co-immunoprecipitation (Co-IP): Identifying interactors like Cdc11p, Myo1p, and Elm1 kinase .
Bni5p binds directly to the N-terminal domain of Cdc11p, stabilizing the septin ring. Deletion of BNI5 exacerbates septin mislocalization in cdc3, cdc10, cdc11, or cdc12 mutants .
Bni5p depletion delays septin hourglass-to-double-ring remodeling, impairing actomyosin ring (AMR) constriction .
Bni5p tethers Myo1p to septins via its N-terminal coiled-coil (CC1) domain. This interaction enhances Myo1p accumulation at the bud neck, ensuring AMR robustness during cytokinesis .
Bni5p-Myo1p binding mediates RACF, which drives asymmetric segregation of mitochondria and protein aggregates (e.g., Htt103Q-GFP) to mother cells .
Tagging Position Matters: C-terminal GFP tags delay Bni5p recruitment and reduce functionality compared to N-terminal tags .
Dynamic Localization: Fluorescence recovery after photobleaching (FRAP) shows Bni5p-N-GFP has slow turnover (~60% immobile fraction), similar to septins .
Strain Dependency: BNI5 deletion phenotypes vary across yeast strains, potentially due to genetic background effects .
KEGG: sce:YNL166C
STRING: 4932.YNL166C
Bni5 is a protein found in Saccharomyces cerevisiae and other fungal species that localizes to the bud neck after bud emergence during the period when the septin collar becomes stabilized. It functions as a critical bridge between septin filaments and the type II myosin (Myo1) required for assembly of the actomyosin contractile ring that drives plasma membrane ingression during cytokinesis . Bni5 absence results in growth defects and exacerbates phenotypes (elongated cell shape and cell cycle arrest) conferred by septin mutations . Recent studies have revealed that Bni5 has at least three distinct functions: regulating timely remodeling of the septin hourglass to a double ring (enabling AMR constriction), increasing Myo1 levels at the bud neck before cytokinesis, and enhancing retrograde actin flow (RACF), which contributes to asymmetric segregation of mitochondria-tethered protein aggregates .
Bni5 interacts preferentially with Cdc11, the terminal subunit at the junctions between adjacent hetero-octamers in paired septin filaments . This interaction is highly cooperative and involves both the C-terminal end of Bni5 and the C-terminal extension (CTE) of Cdc11 . The anti-parallel coiled-coil of a Bni5 monomer is captured by forming a three-helix bundle with the CTE of a Cdc11 subunit, with the C-terminal helix of Bni5 making the primary contacts with the Cdc11 CTE . This tethering increases the local concentration of Bni5, facilitating its dimerization via a hinge domain-hinge domain interaction, similar to SMC proteins . As more Bni5 molecules bind, paired filaments draw closer together, enhancing further Bni5 binding through a "zippering up" effect, which explains the observed cooperativity .
Researchers employ multiple complementary techniques to study Bni5:
FRET analysis: Used to examine the association of fluorescently labeled Bni5 with septin filaments, revealing specific interaction domains
Electron microscopy: Provides ultrastructural visualization of how Bni5 affects septin filament organization
Analytical ultracentrifugation: Demonstrates Bni5's propensity to dimerize and its elongated structure
Field-flow fractionation with multi-angle light scattering (FFF-MALS): Confirms Bni5's oligomerization properties, showing monomeric, dimeric, and tetrameric populations
Structure prediction using AlphaFold: Enables prediction of Bni5's structure for targeted functional analysis
Quantitative live-cell imaging: Allows temporal tracking of Bni5 localization during the cell cycle
Gene editing: Facilitates creation of modified Bni5 variants to test domain functions
Experimental evidence demonstrates that the position of fluorescent protein tagging significantly affects Bni5 functionality. Both C-terminally tagged (Bni5-C-GFP) and N-terminally tagged (Bni5-N-GFP) proteins localize to the bud neck with septins, but they exhibit important functional differences . N-terminal tagging allows Bni5 to arrive at the presumptive bud site simultaneously with septins, while C-terminally tagged Bni5 arrives approximately 12 minutes later, around bud emergence . Additionally, Bni5-N-GFP accumulates at the bud neck approximately 32% more than Bni5-C-GFP .
In temperature-sensitive septin mutant suppression assays, N-terminally tagged Bni5 functions similarly to untagged Bni5, suppressing growth and morphological defects at both permissive (25°C) and restrictive (32°C) temperatures. In contrast, C-terminally tagged Bni5 only suppresses defects at the permissive temperature . These findings indicate that while C-terminal tagging does not overtly affect Bni5's localization or its role as a septin-myosin-II linker, it compromises its function in septin regulation . For experiments focused on Bni5's complete functionality, researchers should use N-terminal tagging or untagged constructs.
When studying Bni5-septin interactions, researchers should include:
Cys mutant controls: When using FRET or other fluorescence-based techniques with thiol-reactive dyes, consider the importance of Bni5's three Cys residues (C144, C266, and C375). C375 is invariant across species and embedded in a well-conserved sequence, suggesting functional importance . Studies show that Bni5 C375S mutations may affect protein stability .
Truncation controls: Include Bni5 truncation constructs such as Bni5(1-313), MBP-Bni5(314-448), and Bni5(ΔHD) (with residues 133-283 deleted) to assess domain-specific contributions to function and oligomerization .
Septin mutants: cdc11 truncation alleles are particularly informative as they have synthetic growth defects with tagged Bni5, especially C-terminally tagged versions . The temperature-sensitive cdc12-6 mutant offers a valuable background for testing Bni5 function through suppression assays .
Time-point controls: Due to the dynamic nature of Bni5 localization during the cell cycle, time-lapse imaging with alignment based on cell cycle-specific events (septin accumulation at budding site, spindle breakage) provides crucial temporal context .
Characterizing Bni5's role in septin organization requires a multi-faceted approach:
Structural analysis: Combining FRET analysis with electron microscopy provides comprehensive insights into how Bni5 binding affects septin filament arrangement. FRET studies using fluorescently labeled Bni5 and Cdc11 have revealed that Bni5 binding is highly cooperative and involves specific domains .
Ultrastructural visualization: Electron microscopy demonstrates that Bni5 binding significantly narrows the gap between paired septin filaments and imposes more uniform spacing. By sequestering the CTEs of Cdc11 subunits, Bni5 alleviates distance constraints, allowing filament pairs to draw closer together .
Oligomerization studies: Field-flow fractionation with multi-angle light scattering reveals that Bni5 forms monomeric, dimeric, and tetrameric species, with the hinge domain (residues 133-283) being critical for multimerization . This property is essential for understanding how Bni5 forms cross-filament braces.
Domain-specific functional assays: Targeted mutations or deletions of specific Bni5 domains, particularly the hinge domain and C-terminal region, coupled with live cell imaging, can determine which regions are necessary for septin organization versus other functions like Myo1 recruitment .
The molecular mechanism of Bni5-mediated septin filament organization involves several coordinated steps:
Initial binding: The C-terminal helix of a Bni5 monomer forms a three-helix bundle with the CTE of a Cdc11 subunit, tethering Bni5 to the septin filament .
Dimerization: Once tethered, Bni5 molecules dimerize via their hinge domains, similar to SMC proteins, likely in a parallel fashion .
Cooperative binding: After initial binding, additional Bni5 monomers are captured through two additive contacts—forming a three-helix bundle with nearby Cdc11 subunits and dimerizing with adjacent already-tethered Bni5 monomers .
Oligomerization: Further enhancement in binding at Cdc11-Cdc11 junctions may arise from pairing of bound Bni5 dimers to form homo-tetramers .
Filament zippering: As more Bni5 molecules bind, paired filaments draw closer together, facilitating additional Bni5 dimerization in a "zippering up" effect that explains the observed binding cooperativity .
CTE sequestration: By sequestering the CTEs of Cdc11 subunits, Bni5 alleviates distance constraints between paired filaments, allowing them to draw closer together and adopt more uniform spacing .
Bni5 establishes a specific biochemical pathway (septin-Bni5-Myo1) at the division site that controls the efficiency, fidelity, and robustness of various cellular processes . This pathway operates through several mechanisms:
Septin-myosin linking: Bni5 functions as a critical bridge between septin filaments and Myo1, the type II myosin required for assembly of the actomyosin contractile ring (AMR) that drives plasma membrane ingression during cytokinesis .
Septin structure remodeling: Bni5 regulates the timely remodeling of the septin hourglass to a double ring, which is essential for AMR constriction .
Myo1 recruitment and retention: Bni5 is responsible for increasing Myo1 levels at the bud neck before cytokinesis onset, which strengthens the AMR against various genetic and chemical perturbations .
Retrograde actin flow enhancement: By binding to a specific region in the Myo1 tail, Bni5 enhances retrograde actin flow (RACF), which contributes to the asymmetric segregation of mitochondria-tethered protein aggregates related to cellular aging and health .
While the search results don't specifically address Bni5 antibodies, we can infer several challenges based on the protein's properties:
Structural considerations: Bni5's elongated structure with hinge domains and coiled-coil segments may present conformational epitopes that are difficult to capture with antibodies .
Oligomerization effects: Bni5's propensity to form dimers and tetramers could mask epitopes in oligomeric forms that are accessible in monomeric forms .
Post-translational modifications: Phosphorylation of Bni5 contributes to its interactions with Cdc11 and its displacement from the bud neck in late mitosis . Antibodies may have different affinities for phosphorylated versus non-phosphorylated forms.
Cross-reactivity considerations: When working with Bni5 orthologues from different fungal species, researchers should be aware of sequence variations. While C375 is invariant across species, other regions show greater divergence .
Epitope accessibility in complexes: Bni5's interactions with septin filaments and Myo1 may obscure antibody binding sites in cellular contexts, potentially affecting immunoprecipitation or immunofluorescence applications .
To differentiate between direct and indirect effects of Bni5 on cell division:
Domain-specific mutations: Create targeted mutations in specific Bni5 domains that disrupt particular interactions while preserving others. For example, mutations that specifically disrupt Bni5-Cdc11 interaction versus those that disrupt Bni5-Myo1 interaction .
Temporal analysis: Use time-lapse imaging to correlate Bni5 dynamics with specific cellular events. The differential timing of N-terminally versus C-terminally tagged Bni5 arrival at the bud neck highlights the importance of precise temporal analysis .
Separation-of-function alleles: Generate Bni5 variants that specifically lack one function while maintaining others. Targeted mutations in the C-terminal region might disrupt Cdc11 binding while preserving other functions .
In vitro reconstitution: Use purified components to reconstitute specific interactions and activities, such as Bni5-mediated changes in septin filament organization or Myo1 recruitment, to establish direct biochemical effects .
Conditional depletion systems: Implement systems for rapid, conditional depletion of Bni5 to distinguish immediate effects (likely direct) from delayed effects (possibly indirect) on septin organization, Myo1 localization, and cytokinesis .
The discovery that Bni5 enhances retrograde actin flow, which contributes to the asymmetric segregation of mitochondria-tethered protein aggregates related to cellular aging and health , opens several promising research directions:
Aging pathway connections: Investigate how Bni5-mediated segregation of protein aggregates interacts with known aging pathways in yeast, potentially revealing conserved mechanisms relevant to higher eukaryotes.
Stress response integration: Explore how Bni5 function might be modulated under various stress conditions that accelerate aging, and whether Bni5-mediated processes represent adaptable response mechanisms.
Protein quality control: Examine the relationship between Bni5-enhanced retrograde actin flow and protein quality control systems, potentially revealing new connections between cytokinesis machinery and proteostasis.
Conservation in metazoans: Identify potential functional homologues of Bni5 in higher eukaryotes that might fulfill similar roles in asymmetric segregation of damaged cellular components during cell division.
Therapeutic implications: Explore whether manipulation of Bni5-like pathways could offer therapeutic approaches for age-related diseases characterized by protein aggregation.
Understanding Bni5's structure-function relationships could inform the development of several research tools:
Domain-specific probes: The identification of functional domains in Bni5, particularly its C-terminal region that interacts with Cdc11 and its hinge domain involved in oligomerization , provides targets for developing domain-specific probes that could monitor specific interactions in living cells.
Split-protein reporters: Based on Bni5's dimerization properties, researchers could develop split-protein reporters that reconstitute activity when Bni5 dimerizes, providing real-time readouts of Bni5 oligomerization states.
Structure-guided antibody development: The AlphaFold-predicted structure of Bni5 could guide the development of conformation-specific antibodies that recognize specific functional states of the protein.
Engineered variants: Structure-informed engineering of Bni5 variants with enhanced or diminished specific functions could serve as valuable tools for dissecting the contributions of different Bni5 activities to cell division and aging.
Cross-linking strategies: Knowledge of Bni5's elongated structure and its interaction interfaces with septins and Myo1 could inform the development of cross-linking strategies to capture transient protein complexes at the cytokinetic apparatus.